These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 10362343

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Are There Cochlear Dead Regions Involved in Hearing Loss after Cisplatin Ototoxicity?
    Schultz C, Pecora Liberman PH, Schmidt Goffi-Gomez MV.
    Audiol Neurootol; 2019; 24(5):253-257. PubMed ID: 31661686
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [The "Muenster classification" of high frequency hearing loss following cisplatin chemotherapy].
    Schmidt CM, Bartholomäus E, Deuster D, Heinecke A, Dinnesen AG.
    HNO; 2007 Apr; 55(4):299-306. PubMed ID: 16437215
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Ototoxicity due to cis-diamminedichloroplatinum in the treatment of ovarian cancer: influence of dosage and schedule of administration.
    Waters GS, Ahmad M, Katsarkas A, Stanimir G, McKay J.
    Ear Hear; 1991 Apr; 12(2):91-102. PubMed ID: 2065844
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Validation of Hearing Loss Prediction Tool for Cisplatin Chemotherapy and Radiation in Head and Neck Cancer Treatment.
    Deutsch BC, Collopy C, Kallogjeri D, Piccirillo JF.
    JAMA Otolaryngol Head Neck Surg; 2021 Feb 01; 147(2):182-189. PubMed ID: 33300954
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. High frequency audiometry in prospective clinical research of ototoxicity due to platinum derivatives.
    van der Hulst RJ, Dreschler WA, Urbanus NA.
    Ann Otol Rhinol Laryngol; 1988 Feb 01; 97(2 Pt 1):133-7. PubMed ID: 3281541
    [Abstract] [Full Text] [Related]

  • 16. Ototoxicity from cisplatin therapy in childhood cancer.
    Coradini PP, Cigana L, Selistre SG, Rosito LS, Brunetto AL.
    J Pediatr Hematol Oncol; 2007 Jun 01; 29(6):355-60. PubMed ID: 17551394
    [Abstract] [Full Text] [Related]

  • 17. The Role of Audiometry prior to High-Dose Cisplatin in Patients with Head and Neck Cancer.
    Caballero M, Mackers P, Reig O, Buxo E, Navarrete P, Blanch JL, Grau JJ.
    Oncology; 2017 Jun 01; 93(2):75-82. PubMed ID: 28511189
    [Abstract] [Full Text] [Related]

  • 18. Dose-related alpha-difluoromethylornithine ototoxicity.
    Croghan MK, Aickin MG, Meyskens FL.
    Am J Clin Oncol; 1991 Aug 01; 14(4):331-5. PubMed ID: 1862765
    [Abstract] [Full Text] [Related]

  • 19. Feasibility and first results of a prospective cohort study to investigate cisplatin-associated ototoxicity amongst cancer patients in South Africa.
    Paken J, Govender CD, Pillay M, Ayele BT, Sewram V.
    BMC Cancer; 2021 Jul 16; 21(1):822. PubMed ID: 34271863
    [Abstract] [Full Text] [Related]

  • 20. The use of high-frequency audiometry increases the diagnosis of asymptomatic hearing loss in pediatric patients treated with cisplatin-based chemotherapy.
    Abujamra AL, Escosteguy JR, Dall'Igna C, Manica D, Cigana LF, Coradini P, Brunetto A, Gregianin LJ.
    Pediatr Blood Cancer; 2013 Mar 16; 60(3):474-8. PubMed ID: 22744939
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.